Revised SPC: Xyrem (sodium oxybate) 500 mg/ml oral solution

SPC updated with paediatric license extension (treatment of narcolepsy with cataplexy in children from > 7 years); a warning regarding sleep apnoea with advice to monitor for respiratory depression and addition of anxiety, bipolar disorder and psychosis as adverse events.

electronic Medicines compendium